ASEAN MedTech Insights
Pure Global's Guide to Singapore's MedTech Regulations: Unlocking ASEAN Market Access Through Technical Specifications
25 Sep 2025
In this episode of ASEAN MedTech Insights, we demystify the core technical specifications required under Singapore's Health Products (Medical Devices) Regulations 2010. We explore why Singapore serves as a crucial launchpad for the broader ASEAN market and break down the specific documentation demands of the Health Sciences Authority (HSA). We delve into the ASEAN Common Submission Dossier Template (CSDT), detailing the critical elements that manufacturers often overlook, from granular device descriptions and material specifications to the rigorous standards for labelling and clinical evidence. This episode is essential listening for any MedTech company planning a Southeast Asian market entry strategy. Case Study: Imagine launching a revolutionary Class C cardiovascular device, only to face months of delays because your clinical evidence dossier didn't meet the HSA's specific expectations for local population data. This common pitfall can cost millions in lost revenue and market opportunity, a challenge we help you understand and avoid. Key Takeaways: 1. What is the ASEAN CSDT and why is it the backbone of your Singapore submission? 2. How do Singapore's risk classifications (Class A, B, C, D) directly impact your technical documentation requirements? 3. What are the specific labelling and Instructions For Use (IFU) requirements you absolutely cannot ignore? 4. Does your existing clinical data from the US or EU meet the Health Sciences Authority's standards? 5. How can you leverage Singapore's registration as a stepping stone for other ASEAN markets? 6. What are the essential elements of a robust ISO 14971 risk management file that the HSA expects to see? 7. Beyond product testing, what specific details on manufacturing processes must be included in the dossier? Struggling to align your technical documentation with the demands of multiple markets? Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies. We combine local expertise with advanced AI and data tools to streamline global market access. Let us help you turn a single, robust registration process into access for over 30 countries. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
TNB Tech Minute: FTC Orders Instacart to Pay $60 Million Over Deceptive Practices
18 Dec 2025
WSJ Tech News Briefing
Hidden Gem Stocks We Love at the End of the Year
18 Dec 2025
Motley Fool Money
Google Undercuts the Field, OpenAI Builds an App OS, and China Accelerates
18 Dec 2025
The Daily AI Show
Lucy Liu
18 Dec 2025
Fresh Air
#2428 - Michael P. Masters
18 Dec 2025
The Joe Rogan Experience